drugset / Trial / NCT04803318
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
To study the clinical effect of Trametinib combined with Everolimus and Lenvatinib in the treatment of Recurrent/Refractory advanced solid tumors.
Timeline
- Start
- 2021-01-01
- Primary completion
- 2029-01-01
- Completion
- 2037-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | Oral |
| Subject | Lenvatinib | Small molecule | — | Oral |
| Subject | Trametinib | Small molecule | — | Oral |